These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28771321)

  • 21. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine.
    Sundström M; Pelander A; Angerer V; Hutter M; Kneisel S; Ojanperä I
    Anal Bioanal Chem; 2013 Oct; 405(26):8463-74. PubMed ID: 23954996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
    Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous screening of 239 synthetic cannabinoids and metabolites in blood and urine samples using liquid chromatography-high resolution mass spectrometry.
    Shi Y; Liu M; Li X; Xu N; Yuan S; Yu Z; Xiang P; Wu H
    J Chromatogr A; 2022 Jan; 1663():462743. PubMed ID: 34974369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine.
    Wouters E; Mogler L; Cannaert A; Auwärter V; Stove C
    Drug Test Anal; 2019 Aug; 11(8):1183-1191. PubMed ID: 31021521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls.
    Möller I; Wintermeyer A; Bender K; Jübner M; Thomas A; Krug O; Schänzer W; Thevis M
    Drug Test Anal; 2011 Sep; 3(9):609-20. PubMed ID: 20872894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review.
    Navarro-Tapia E; Codina J; Villanueva-Blasco VJ; García-Algar Ó; Andreu-Fernández V
    Biology (Basel); 2022 May; 11(5):. PubMed ID: 35625524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity-based reporter assays for the screening of abused substances in biological matrices.
    Cannaert A; Vandeputte M; Wille SMR; Stove CP
    Crit Rev Toxicol; 2019 Feb; 49(2):95-109. PubMed ID: 30919714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry.
    Park M; Yeon S; Lee J; In S
    J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine.
    Kanamori T; Kanda K; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
    Drug Test Anal; 2015 Apr; 7(4):341-5. PubMed ID: 25600155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.
    Armenian P; Darracq M; Gevorkyan J; Clark S; Kaye B; Brandehoff NP
    Neuropharmacology; 2018 May; 134(Pt A):82-91. PubMed ID: 29037744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling.
    Walsh KB; Andersen HK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period.
    Tuv SS; Krabseth H; Karinen R; Olsen KM; Øiestad EL; Vindenes V
    Accid Anal Prev; 2014 Jan; 62():26-31. PubMed ID: 24129318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.